Recently, HOTAIR has been determined to be a negative prognostic indicator in breast, colon, liver, and pancreatic cancer patient survival, and increased HOTAIR expression in patients has been correlated with enhanced breast and colon cancer metastasis. This evidence concerns the gene HOTAIR and familial pancreatic carcinoma.